Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bladder mast cell activation in interstitial cystitis.

T C Theoharides1, G R Sant

  • 1Department of Pharmacology, Tufts University School of Medicine, New England Medical Center, Boston, MA 02111.

Seminars in Urology
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurohormonal markers in chronic rhinosinusitis.

Journal of biological regulators and homeostatic agents·2021
Same author

Be aware of SARS-CoV-2 spike protein: There is more than meets the eye.

Journal of biological regulators and homeostatic agents·2021
Same author

Antibodies for COVID-19 - which, when and how long?

Journal of biological regulators and homeostatic agents·2021
Same author

COVID-19 and Multisystem Inflammatory Syndrome, or is it Mast Cell Activation Syndrome?

Journal of biological regulators and homeostatic agents·2020
Same author

IL-1 Superfamily Members and Periodontal Diseases.

Journal of dental research·2020
Same author

Dexamethasone for COVID-19? Not so fast.

Journal of biological regulators and homeostatic agents·2020

Bladder mast cells release chemicals that cause pain and damage, contributing to interstitial cystitis (IC). Inhibiting mast cell activation may offer therapeutic benefits for IC patients.

Area of Science:

  • Urology
  • Immunology
  • Neuroscience

Background:

  • Bladder mast cells contain granules that release vasoactive and nociceptive molecules.
  • Various stimuli (cold, drugs, stress, toxins) can trigger mast cell degranulation.
  • Mast cell mediators can sensitize sensory neurons, creating a positive feedback loop that exacerbates bladder dysfunction.

Purpose of the Study:

  • To explore the role of bladder mast cells in interstitial cystitis (IC).
  • To identify potential diagnostic markers and therapeutic targets related to mast cell activity in IC.

Main Methods:

  • Review of existing literature on mast cell function and IC pathophysiology.
  • Discussion of potential diagnostic assays for mast cell mediators.
  • Consideration of therapeutic strategies targeting mast cell degranulation.

Related Experiment Videos

Main Results:

  • Mast cell activation leads to vasodilation, mucosal damage, and inflammatory cell recruitment in the bladder.
  • The complex interplay of triggers and mediators presents a challenge for clinicians treating IC.
  • Mast cell mediators show potential as diagnostic tools for IC.

Conclusions:

  • Mast cell degranulation significantly contributes to IC symptoms and pathology.
  • Inhibiting mast cell activation is a promising therapeutic strategy for IC.
  • Further research is needed to validate diagnostic assays and therapeutic inhibitors for mast cell-related bladder conditions.